John J. Sperzel III

Insider Reports History

Location
61 Crestview Lane, Brunswick, ME
Signature
/s/ John Sprague, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John J. Sperzel III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
T2 Biosystems, Inc. Chairman, President & CEO, Director Restricted Stock Units 490K $77.2K $0.16 Nov 4, 2024 Direct
T2 Biosystems, Inc. Chairman, President & CEO, Director Common Stock 400 $63.00 $0.16 Feb 24, 2024 Direct

Insider Reports Filed by John J. Sperzel III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TTOO T2 Biosystems, Inc. Nov 4, 2024 2 $0 4 Jan 2, 2025 Chairman, President & CEO, Director
TTOO T2 Biosystems, Inc. Feb 24, 2024 2 $0 4 Feb 27, 2024 Officer, Director
TTOO T2 Biosystems, Inc. Feb 20, 2024 2 $0 4 Feb 20, 2024 Chairman, President and Chief Executive Officer, Director
TTOO T2 Biosystems, Inc. Feb 20, 2023 6 -$6.18K 4 Mar 9, 2023 Chairman and CEO, Director
TTOO T2 Biosystems, Inc. Apr 7, 2022 1 $15K 4 Apr 11, 2022 Chairman, CEO, and President, Director
TTOO T2 Biosystems, Inc. Feb 24, 2022 3 -$63.5K 4 Feb 28, 2022 Chairman, Chief Executive Officer and President, Director
TTOO T2 Biosystems, Inc. Feb 20, 2022 1 $0 4 Feb 23, 2022 Chairman, President and Chief Executive Officer, Director